Literature DB >> 11132209

The relationship between serum levels of YKL-40 and disease progression in patients with early rheumatoid arthritis.

S Harvey1, J Whaley, K Eberhardt.   

Abstract

YKL-40 concentrations in serum were determined by an ELISA at 3 occasions during 19 months for 57 early RA patients. The results were related to biochemical and radiographic measures at each time point. YKL-40 correlated significantly to ESR and CRP throughout the study. Correlations between YKL-40 and radiographic findings scored by the Larsen method were fairly weak both for absolute values at each time point (Rs 0.212-0.319) and for progression over time (Rs 0.152-0.301). Baseline YKL-40 could predict radiographic progression with a specificity and sensitivity of only slightly over 50%. ESR and CRP correlated stronger than YKL-40 to joint damage progression and in a multiple regression model ESR was the only significant variable explaining the variance of this radiographic measure. We conclude that serial measurements of serum YKL-40 did not provide information that could not be obtained by conventional biochemical measures of disease activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11132209     DOI: 10.1080/030097400447606

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  5 in total

Review 1.  The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review.

Authors:  Kalthoum Tizaoui; Jae Won Yang; Keum Hwa Lee; Ji Hong Kim; Minseok Kim; Sojung Yoon; Yeonwoo Jung; Joon Beom Park; Kitae An; Hyeok Choi; Donggyu Song; HyunTaek Jung; Seongmin Ahn; Taeho Yuh; Hee Min Choi; Jae Ha Ahn; Younjuong Kim; Sanghyun Jee; Hyeongsun Lee; Soohwa Jin; Jun-Gu Kang; Bohyun Koo; Joo Yeop Lee; Kyoung Min Min; Wonseok Yoo; Hyeong Jun Rhyu; Yeonjung Yoon; Min Ho Lee; Sung Eun Kim; Jimin Hwang; Ai Koyanagi; Louis Jacob; Seoyeon Park; Jae Il Shin; Lee Smith
Journal:  Int J Biol Sci       Date:  2022-05-21       Impact factor: 10.750

2.  Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects.

Authors:  Kaspar R Nielsen; Rudi Steffensen; Martin Boegsted; John Baech; Soeren Lundbye-Christensen; Merete L Hetland; Sophine B Krintel; Hans E Johnsen; Mette Nyegaard; Julia S Johansen
Journal:  Arthritis Res Ther       Date:  2011-06-29       Impact factor: 5.156

3.  YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?

Authors:  Nicolai A Schultz; Julia S Johansen
Journal:  Cancers (Basel)       Date:  2010-07-12       Impact factor: 6.639

4.  Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1.

Authors:  Yuen Yee Ho; Murray Baron; Anneliese D Recklies; Peter J Roughley; John S Mort
Journal:  BBA Clin       Date:  2014-01-08

Review 5.  Chitinase-3 like-protein-1 function and its role in diseases.

Authors:  Ting Zhao; Zhongping Su; Yingchang Li; Xiaoren Zhang; Qiang You
Journal:  Signal Transduct Target Ther       Date:  2020-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.